|
1
|
|
Sep 22, 2026
|
14:00
|
0
|
KL:B-307
|
Výuka nahrazená blokovou výukou
|
Ing. Gleb Donin, Ph.D.
|
|
2
|
|
Sep 29, 2026
|
14:00
|
2
|
KL:B-307
|
Critical appraisal and reporting standards for economic evaluations
|
Ing. Gleb Donin, Ph.D.
|
|
3
|
|
Oct 6, 2026
|
14:00
|
2
|
KL:B-307
|
Clinical effectiveness inputs and derivation of probabilities for modelling
|
Ing. Vojtěch Kamenský, Ph.D.
|
|
4
|
|
Oct 13, 2026
|
14:00
|
2
|
KL:B-307
|
Sources of cost data and price referencing in the Czech Republic
|
Ing. Gleb Donin, Ph.D.
|
|
5
|
|
Oct 20, 2026
|
14:00
|
2
|
KL:B-307
|
Valuation of health benefits: sources of utilities and disutilities
|
Ing. Ondřej Gajdoš, Ph.D.
|
|
6
|
|
Oct 27, 2026
|
14:00
|
2
|
KL:B-307
|
Decision-analytic models in TreeAge
|
Ing. Ondřej Gajdoš, Ph.D.
|
|
7
|
|
Nov 3, 2026
|
14:00
|
2
|
KL:B-307
|
The Czech reimbursement system and assessment of pharmacoeconomic evidence
|
|
|
8
|
|
Nov 10, 2026
|
14:00
|
2
|
KL:B-307
|
Economic evaluation of medical devices and screening programmes
|
|
|
9
|
|
Nov 17, 2026
|
14:00
|
0
|
KL:B-307
|
státní svátek
|
|
|
10
|
|
Nov 24, 2026
|
14:00
|
2
|
KL:B-307
|
Czech and Slovak reimbursement systems in international context. The EU HTA Regulation.
|
|
|
11
|
|
Dec 1, 2026
|
14:00
|
2
|
KL:B-307
|
Real-world data and registries in economic evaluation
|
Ing. Gleb Donin, Ph.D.
|
|
12
|
|
Dec 8, 2026
|
14:00
|
2
|
KL:B-307
|
Budget impact analysis, cost-effectiveness threshold and risk-sharing instruments
|
|
|
13
|
|
Dec 15, 2026
|
14:00
|
2
|
KL:B-307
|
Multi-criteria decision analysis in reimbursement decisions
|
|
|
14
|
|
Jan 5, 2027
|
14:00
|
2
|
KL:B-307
|
Summary
|
|